spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Fibrin Sealant 

 HSMN NewsFeed - 6 Dec 2022
Corza Medical Announces Key Executive Appointments
Devices Personnel
 HSMN NewsFeed - 9 Jan 2018
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
Devices Surgery Product Launch
 HSMN NewsFeed - 2 Sep 2016
Avita Medical's Regenerative Skin Technology Significantly Reduces Burn Scars and Healing Time
Devices Regenerative Medicine
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2013
Spinal Restoration, Inc. Announces Disappointing Phase III Study Results for the Biostat(R) System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Jun 2013
The Medicines Company Signs Agreement to Acquire ProFibrix
Biopharmaceuticals Surgery Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2013
The Medicines Company and Bristol-Myers Squibb Begin Global Alliance for Recothrom(R)
Biopharmaceuticals Surgery Licensing Distribution
 HSMN NewsFeed - 12 Dec 2012
The Medicines Company and Bristol-Myers Squibb Agree to Global Alliance for Recothrom(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Dec 2012
FDA Approves EVARREST(TM) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 22 Oct 2012
Spinal Restoration, Inc. Closes $5 Million Equity and Debt Financing Round
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Devices Acquisitions
 HSMN NewsFeed - 30 Jan 2012
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery
Devices Surgery FDA
 HSMN NewsFeed - 17 Jan 2012
Cytomedix Appoints Cathryn Hope as Vice President of Marketing
Regenerative Medicine Personnel
 HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Devices FDA
 HSMN NewsFeed - 2 Jun 2011
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
Devices FDA
 HSMN NewsFeed - 7 Jul 2010
Ethicon, Inc. Expands Hemostasis Product Portfolio with Approval of the Company's First Synthetic Internal Use Sealant
Devices FDA
 HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
Devices Surgery Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Apr 2010
ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 6 Apr 2010
Baxter and Nycomed Announce FDA Approval of TachoSil(R)
Devices Surgery FDA
 HSMN NewsFeed - 16 Mar 2010
Spinal Restoration Initiates Patient Enrollment for Phase III Study of Company's Biostat(R) System
Devices Orthopaedic
 HSMN NewsFeed - 11 Nov 2009
Covidien Introduces First FDA-Approved Spine Sealant
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Jun 2009
Spinal Restoration Announces the Submission of the Investigational Device Exemption (IDE) Pilot Study Results for the Biostat System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care
 HSMN NewsFeed - 24 Nov 2008
Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Oct 2008
Omrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human)
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 1 Oct 2008
Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Devices Personnel
 HSMN NewsFeed - 9 Sep 2008
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 25 Jul 2008
Omrix Biopharmaceuticals Receives Positive Opinion from Committee for Medicinal Products for Human Use (CHMP) for Evicel(TM) Liquid Fibrin Sealant (Human)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Jun 2008
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress (TM)
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 15 May 2008
Haemacure appoints Reinaldo M. Diaz to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2008
Spinal Restoration, Inc. Receives FDA IDE Approval
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 30 Apr 2008
ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (Recombinant) Spray Study in Burn Patients
Biopharmaceuticals Wound Care
 HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Devices FDA
 HSMN NewsFeed - 5 Nov 2007
Bayer Temporarily Suspends Global Trasylol(R) Marketing
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2007
ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 12 Sep 2007
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Sep 2007
Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Thrombin Stand Alone, EVITHROM* Thrombin, Topical (Human), with General Hemostasis in Surgery Indication
Biopharmaceuticals Wound Care Surgery FDA
 HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Obtains FDA Clearance to Market CryoSeal(R) Fibrin Sealant (FS) in Liver Resection Surgeries
Devices FDA Surgery
 HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director
Devices Personnel
 HSMN NewsFeed - 30 Jul 2007
OMRIX Biopharmaceuticals Submits Market Authorization Application (MAA) to European Medicines Agency (EMEA) for Approval to Market Evicel(TM) with General Hemostasis Indication
Biopharmaceuticals Surgery Regulatory
 HSMN NewsFeed - 10 Jul 2007
Spinal Restoration and Baxter Announce Agreement for Developing Spinal Disc Application
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Jul 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval to Use Cryoprecipitate from Talecris Biotherapeutics, Inc. in Its Manufacturing Process
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Devices Regenerative Medicine
 HSMN NewsFeed - 15 May 2007
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Liquid Fibrin Sealant, Evicel(TM), For Use in Vascular Surgery
Devices FDA
 HSMN NewsFeed - 25 Apr 2007
ThermoGenesis Announces Record Revenues and Key Executive Changes
Devices Personnel
 HSMN NewsFeed - 8 Mar 2007
OMRIX Biopharmaceuticals Submits Supplemental Biologics License Application (sBLA) to Market Evicel With General Hemostasis in Surgery Indication
Biopharmaceuticals Surgery
 HSMN NewsFeed - 15 Feb 2007
ThermoGenesis Corp. Names Cell Therapy Device Sales Expert Daniel A. Segal as Vice President of Sales & Marketing
Devices Personnel
 HSMN NewsFeed - 25 Jan 2007
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
Biopharmaceuticals
 HSMN NewsFeed - 3 Jan 2007
ThermoGenesis Corp. Appoints Industry Veteran William Osgood as General Manager of Operations
Devices Personnel
 HSMN NewsFeed - 27 Dec 2006
OMRIX Biopharmaceuticals Files Investigational New Drug (IND) Application For Anti-Adhesion Product Candidate and Announces Recent Milestone Achievements
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 15 Dec 2006
Bayer Pharmaceuticals Corporation Informs Health Care Professionals of Important Safety Revisions to the Trasylol Label
Biopharmaceuticals
 HSMN NewsFeed - 9 Nov 2006
Successful Results of the 'Randomized, Prospective, Multi-Center Trial' for the MedClose(TM) VCS
Devices Interventional
 HSMN NewsFeed - 6 Nov 2006
OMRIX Biopharmaceuticals Submits Biologics License Application (BLA) for Human Thrombin Stand-Alone Product
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2006
OMRIX Biopharmaceuticals Announces Positive Phase 3 Clinical Trial Results for Human Thrombin
Biopharmaceuticals Surgery
 HSMN NewsFeed - 29 Sep 2006
OMRIX Biopharmaceuticals Announces New Strategic Product Development Programs
Biopharmaceuticals Surgery Orthopaedic
 HSMN NewsFeed - 10 Jul 2006
OMRIX Biopharmaceuticals Receives FDA Approval for Second Generation Fibrin Sealant, Evicel(TM), For Use in Liver Surgery
Devices Surgery FDA
 HSMN NewsFeed - 26 Jun 2006
Enrollment in Phase III Clinical Trial for OMRIX's Thrombin Stand-Alone Product Has Been Completed
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2006
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
Devices Regenerative Medicine Litigation
 HSMN NewsFeed - 8 May 2006
Med Enclosure, LLC - Management Discussion and Analysis of Food and Drug Administration Compliance
Devices Interventional FDA
 HSMN NewsFeed - 8 May 2006
New Performance Data Presented at ISCT Demonstrates ThermoGenesis' AutoXpress(TM) System (AXP) Efficiently Separates Stem Cells From Cord Blood
Devices Regenerative Medicine
Return to NewsFeed  

 Additional items found! 28

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 28 additional stories matching:
Fibrin Sealant
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.